MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Award Announcements & Progress Reports: Federal Contracts, Grants & Cooperative Agreements
*SBIR-Small Business Innovative Research (Awards)
SBIR:Awardees By Agency
SBIR (Small Business Innovation Research) Program: NIH Awardess
Micronics
Parents
*Architects: Diagnostics_In Vitro Diagnostics (IVD)
*Architects: Laboratory Equipment, Information Systems & Services, Biotechnology, Biology, BioChemistry and Biomanufacturing, Specimens, & Cell Manufacturing, Good Manufacturing Practice (GMP) Software, Supplies & Blood Systems
*Architects: MEMS (MicroElectro Mechanical Systems) Companies
*Industry: Washington
SBIR (Small Business Innovation Research) Program: NIH Awardess
Children
*Key People: Micronics
Current Revenue=$3m (2010)
Founded 1996
Integrated, affordable, sample to result platform for rapid, PCR based detection/differentiation of infectious disease
Investors include Southwest Michigan First Life Science Fund, James Richmond, Jerry Cross, Ardesta, River Cities Capital Funds
Micronics is a leading provider of laboratory-on-a-card ("lab card") design, development and production services on behalf of clients worldwide.
Micronics is believed to offer the most sophisticated and rapid lab card prototyping facility in the world today.
Micronics uniquely integrates other components into its lab cards as well, such as printed reagents, membranes, sensors and electrodes, in order to enable devices that allow rapid, user friendly, point of use detection, monitoring and diagnosis.
Micronics: New Products and Business Developments
Micronics' patented microfluidics and microplumbing technologies, coupled with its expertise in integrating molecular and immunoassays on card, allow it to fundamentally modify the way in which fluids are processed and diagnostic assays are performed at gr
Redmond, Washington
Sales Project=$45.6m in 2014
Saliva Primary Analyte Based Diagnostics
Seeking Series D=$10m
Seeking: Strategic
Jumps
Colonel (Retired) Wilbur Malloy-HJF, TATRC
Dr Paul Yager, Robert F. Rushmer Professor of Bioengineering at the University of Washington
OpGen, Inc. (NASDAQ: OPGN)*